Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Brain Neoplasms 2Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Biopsy 17Specimen Handling 16Magnetic Resonance Spectroscopy 15Cyclophosphamide 14Rituximab 12obinutuzumab 8Lenalidomide 8fludarabine 7Prednisone 7pembrolizumab 6Nuclear Medicine Department, Hospital 6Doxorubicin 5glofitamab 4fludarabine phosphate 4X-Rays 4Vincristine 4Tacrolimus 4Mycophenolic Acid 4Etoposide 4Busulfan 4venetoclax 3trametinib 3sapanisertib 3ibrutinib 3copanlisib 3acalabrutinib 3Whole-Body Irradiation 3Nivolumab 3GSK2636771 3Crizotinib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × Mental Status and Dementia Tests × 30 days × Clear all
NCT05011045 2026-05-20

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

M.D. Anderson Cancer Center

Recruiting
100 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡